{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:19:37Z","timestamp":1770743977147,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3539-1","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T12:32:08Z","timestamp":1544185928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996\u20132016: a retrospective study of clinical characteristics, treatments and outcomes"],"prefix":"10.1186","volume":"18","author":[{"given":"Hedvig","family":"Glans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Dotevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Karlsson","family":"S\u00f6birk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"F\u00e4rnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"3539_CR1","unstructured":"World Health Organ Tech Rep Ser. 2010;(949):xii-xiii, 1-186. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21485694 ."},{"issue":"10","key":"3539_CR2","doi-asserted-by":"crossref","first-page":"19505","DOI":"10.2807\/ese.15.10.19505-en","volume":"15","author":"PD Ready","year":"2010","unstructured":"Ready PD. Leishmaniasis emergence in Europe. Euro Surveill. 2010;15(10):19505.","journal-title":"Euro Surveill"},{"issue":"38","key":"3539_CR3","first-page":"557","volume":"92","author":"WHO","year":"2017","unstructured":"WHO. Global leishmaniasis update, 2006\u20132015: a turning point in leishmaniasis surveillance. Wkly Epidemiol Rec. 2017;92(38):557\u201365.","journal-title":"Wkly Epidemiol Rec"},{"issue":"22","key":"3539_CR4","first-page":"287","volume":"91","author":"World Health O","year":"2016","unstructured":"World Health O. Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014. Releve Epidemiol Hebd. 2016;91(22):287\u201396.","journal-title":"Releve Epidemiol Hebd"},{"issue":"5","key":"3539_CR5","doi-asserted-by":"publisher","first-page":"e2832","DOI":"10.1371\/journal.pntd.0002832","volume":"8","author":"CJ Hodiamont","year":"2014","unstructured":"Hodiamont CJ, Kager PA, Bart A, de Vries HJ, van Thiel PP, Leenstra T, et al. Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide. PLoS Negl Trop Dis. 2014;8(5):e2832.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"3539_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1708-8305.2008.00286.x","volume":"16","author":"JA Blum","year":"2009","unstructured":"Blum JA, Hatz CF. Treatment of cutaneous leishmaniasis in travelers 2009. J Trav Med. 2009;16(2):123\u201331.","journal-title":"J Trav Med"},{"key":"3539_CR7","unstructured":"Socialstyrelsen \/ The National Board of Health and Welfare S. [cited 2018 5 November]. Available from: http:\/\/www.socialstyrelsen.se\/statistik\/statistikdatabas\/diagnoserispecialiseradoppenvard ."},{"issue":"2","key":"3539_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/jtm.12089","volume":"21","author":"J Blum","year":"2014","unstructured":"Blum J, Buffet P, Visser L, Harms G, Bailey MS, Caumes E, et al. LeishMan recommendations for treatment of cutaneous and mucosal Leishmaniasis in travelers, 2014. J Travel Med. 2014;21(2):116\u201329.","journal-title":"J Travel Med"},{"issue":"12","key":"3539_CR9","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1093\/cid\/ciw670","volume":"63","author":"N Aronson","year":"2016","unstructured":"Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, et al. Diagnosis and treatment of Leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Inf Dis. 2016;63(12):e202\u2013e64.","journal-title":"Clin Inf Dis"},{"issue":"1","key":"3539_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0166-6851(92)90208-2","volume":"51","author":"GJ Eys van","year":"1992","unstructured":"van Eys GJ, Schoone GJ, Kroon NC, Ebeling SB. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol. 1992;51(1):133\u201342.","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"3539_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0732-8893(03)00093-2","volume":"47","author":"G Schonian","year":"2003","unstructured":"Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, Presber W, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis. 2003;47(1):349\u201358.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3539_CR12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s10096-011-1463-z","volume":"31","author":"AM Montalvo","year":"2012","unstructured":"Montalvo AM, Fraga J, Maes I, Dujardin J-C, Van der Auwera G. Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification. Eur J Clin Microbiol Infect Dis. 2012;31:1453\u201361.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3539_CR13","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. Volume 1","author":"JE Bennett","year":"2015","unstructured":"Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. Volume 1. Philadelphia: Saunders; 2015."},{"issue":"6","key":"3539_CR14","first-page":"279","volume":"109","author":"H Glans","year":"2012","unstructured":"Glans H, Dotevall L. Cutaneous leishmaniasis is a neglected tropical skin infection. Swedish military infected in Afghanistan. Lakartidningen. 2012;109(6):279\u201381.","journal-title":"Lakartidningen"},{"key":"3539_CR15","doi-asserted-by":"publisher","first-page":"805108","DOI":"10.1155\/2013\/805108","volume":"2013","author":"A Strazzulla","year":"2013","unstructured":"Strazzulla A, Cocuzza S, Pinzone MR, Postorino MC, Cosentino S, Serra A, et al. Mucosal leishmaniasis: an underestimated presentation of a neglected disease. Biomed Res Int. 2013;2013:805108.","journal-title":"Biomed Res Int"},{"issue":"4","key":"3539_CR16","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.4269\/ajtmh.17-0162","volume":"97","author":"TA Patel","year":"2017","unstructured":"Patel TA, Scadding GK, Phillips DE, Lockwood DN. Case Report: Old World mucosal Leishmaniasis: Report of five imported cases to the Hospital for Tropical Diseases, London, United Kingdom. Am J Trop Med Hyg. 2017;97(4):1116\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"3539_CR17","unstructured":"Agency SM. [cited 2018 2 Januray]. Available from: https:\/\/www.migrationsverket.se\/Om-Migrationsverket\/Statistik.html ."},{"issue":"12","key":"3539_CR18","doi-asserted-by":"publisher","first-page":"e1032","DOI":"10.1016\/j.ijid.2010.06.019","volume":"14","author":"A Pavli","year":"2010","unstructured":"Pavli A, Maltezou HC. Leishmaniasis, an emerging infection in travelers. Int J Infect Dis. 2010;14(12):e1032\u20139.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"3539_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4269\/ajtmh.2012.10-0558","volume":"86","author":"EC Wall","year":"2012","unstructured":"Wall EC, Watson J, Armstrong M, Chiodini PL, Lockwood DN. Epidemiology of imported cutaneous leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: use of polymerase chain reaction to identify the species. Am J Trop Med Hyg. 2012;86(1):115\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"3539_CR20","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.4269\/ajtmh.2010.10-0143","volume":"83","author":"PP Thiel van","year":"2010","unstructured":"van Thiel PP, Leenstra T, de Vries HJ, van der Sluis A, van Gool T, Krull AC, et al. Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment. Am J Trop Med Hyg. 2010;83(6):1295\u2013300.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"3539_CR21","first-page":"43","volume":"8","author":"JP Woodrow","year":"2006","unstructured":"Woodrow JP, Hartzell JD, Czarnik J, Brett-Major DM, Wortmann G. Cutaneous and presumed visceral leishmaniasis in a soldier deployed to Afghanistan. MedGenMed. 2006;8(4):43.","journal-title":"MedGenMed"},{"issue":"2","key":"3539_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4269\/ajtmh.2009.80.172","volume":"80","author":"P Layegh","year":"2009","unstructured":"Layegh P, Pezeshkpoor F, Soruri AH, Naviafar P, Moghiman T. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children. Am J Trop Med Hyg. 2009;80(2):172\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"3539_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1086\/341406","volume":"35","author":"G Wortmann","year":"2002","unstructured":"Wortmann G, Miller RS, Oster C, Jackson J, Aronson N. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin Infect Dis. 2002;35(3):261\u20137.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3539_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1468-3083.2010.03908.x","volume":"25","author":"M Solomon","year":"2011","unstructured":"Solomon M, Pavlotsky F, Leshem E, Ephros M, Trau H, Schwartz E. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica. J Eur Acad Dermatol Venereol. 2011;25(8):973\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3539_CR25","doi-asserted-by":"crossref","unstructured":"Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Floconazole for the treatment of cutaneous Leishmaniasis caused by Leishmania tropica. N Engl J Med. 2002;346(12):891-95.","DOI":"10.1056\/NEJMoa011882"},{"issue":"3","key":"3539_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaad.2010.04.014","volume":"64","author":"M Emad","year":"2011","unstructured":"Emad M, Hayati F, Fallahzadeh MK, Namazi MR. Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial. J Am Acad Dermatol. 2011;64(3):606\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3539_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4269\/ajtmh.2007.76.48","volume":"76","author":"G Morizot","year":"2007","unstructured":"Morizot G, Delgiudice P, Caumes E, Laffitte E, Marty P, Dupuy A, et al. Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution? Am J Trop Med Hyg. 2007;76(1):48\u201352.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"3539_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000370238","volume":"230","author":"A Catala","year":"2015","unstructured":"Catala A, Roe E, Dalmau J, Pomar V, Munoz C, Yelamos O, et al. Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature. Dermatology. 2015;230(3):204\u20137.","journal-title":"Dermatology"},{"issue":"6","key":"3539_CR29","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1084\/jem.170.6.2097","volume":"170","author":"RG Titus","year":"1989","unstructured":"Titus RG, Sherry B, Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med. 1989;170(6):2097\u2013104.","journal-title":"J Exp Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3539-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T21:15:13Z","timestamp":1662585313000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3539-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3539"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3539-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Central Ethical Review Board in Stockholm (2015\/2162\u201331). As this investigation was a retrospective study that reviewed medical records without revealing the patient\u2019s private information, informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"632"}}